Page last updated: 2024-09-03

deltorphin i, ala(2)- and ufp-502

deltorphin i, ala(2)- has been researched along with ufp-502 in 2 studies

Compound Research Comparison

Studies
(deltorphin i, ala(2)-)
Trials
(deltorphin i, ala(2)-)
Recent Studies (post-2010)
(deltorphin i, ala(2)-)
Studies
(ufp-502)
Trials
(ufp-502)
Recent Studies (post-2010) (ufp-502)
12204600

Protein Interaction Comparison

ProteinTaxonomydeltorphin i, ala(2)- (IC50)ufp-502 (IC50)
Delta-type opioid receptorMus musculus (house mouse)0.0001
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.0355

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balboni, G; Bianchi, C; Bryant, SD; Guerrini, R; Lazarus, LH; Rizzi, D; Salvadori, S1
Balboni, G; Bryant, SD; Giannini, E; Guerrini, R; Jinsmaa, Y; Lazarus, LH; Negri, L; Salvadori, S1

Other Studies

2 other study(ies) available for deltorphin i, ala(2)- and ufp-502

ArticleYear
Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties.
    Journal of medicinal chemistry, 2002, Jan-31, Volume: 45, Issue:3

    Topics: Animals; Brain; Dipeptides; In Vitro Techniques; Ligands; Male; Mice; Oligopeptides; Radioligand Assay; Rats; Receptors, Opioid, delta; Receptors, Opioid, mu; Structure-Activity Relationship; Synaptosomes; Tetrahydroisoquinolines; Vas Deferens

2002
Conversion of the potent delta-opioid agonist H-Dmt-Tic-NH-CH(2)-bid into delta-opioid antagonists by N(1)-benzimidazole alkylation(1).
    Journal of medicinal chemistry, 2005, Dec-29, Volume: 48, Issue:26

    Topics: Alkylation; Animals; Benzimidazoles; Dipeptides; Guinea Pigs; Ileum; Inhibitory Concentration 50; Male; Mice; Rats; Receptors, Opioid, delta; Synaptosomes; Vas Deferens

2005